The activity of β-hexosaminidase (uHex) and γ-glutamyl- transferase (uGGT) in urine as non-invasive markers of chronic alcohol abuse: I. Alcohol-dependent subjects

World Journal of Biological Psychiatry

Volumn 2, Issue 4, 2001, Pages 184-189

  Taracha, Ewa ^a   Habrat, Boguslaw ^a   Woźiak, Piotr ^a   Walkowiak, Jerzy ^a   Szukalski, Bogdan ^a  

^a INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

Author keywords

biological markers of alcohol abuse; CDT; serum glutamyltransferase; urine hexosaminidase; urine glutamyltransferase

Indexed keywords

BETA N ACETYLHEXOSAMINIDASE; BIOLOGICAL MARKER; GAMMA GLUTAMYLTRANSFERASE;

ADULT; ALCOHOLISM; ARTICLE; DRUG DETOXIFICATION; ENZYMOLOGY; HUMAN; MALE; METABOLISM; MIDDLE AGED; ROC CURVE; SENSITIVITY AND SPECIFICITY; URINE;

ADULT; ALCOHOLISM; BETA-N-ACETYLHEXOSAMINIDASE; BIOLOGICAL MARKERS; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; MALE; METABOLIC DETOXICATION, DRUG; MIDDLE AGED; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 0035497644     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622970109026807     Document Type: Article

References (35)

1. Aithal GP, Thornes H, Dwarakanath AD, Tanner AR (1998) Measurement of carbohydrate-deficient transferrin (CDT) in a general medical clinic: is this test useful in assessing alcohol consumption? Alcohol Alcohol 33:304-309.
2. Anton RF, Litten RZ, Allen JP (1995) Biological assessment of alcohol consumption. In: Allen JP, Columbus M (eds) Assessing alcohol problems: a guide for clinicians and researchers. NIAAA Treatment Handbook Series 4. NIAAA, Bethesda, pp 31-39.
3. Bell H, Tallaksen CME, Try K, Haug E (1994) Carbohydrate-deficient transferrin and other markers of high alcohol consumption: a study of 502 patients admitted consecutively to a medical department. Alcohol Clin Exp Res 18:1103-1108.
4. Conigrave KM, Saunders IB, Whitfield JB (1995) Diagnostic tests for alcohol consumption. Alcohol Alcohol 30:13-26.
5. Grzybowski M, Younger JC (1997) Statistical methodology: III. Receiver Operating Characteristic (ROC) curves. Acad Emerg Med 4:818-826.
6. Habrat B, Czartoryska B, Górska D, Poźniak M, Wehr H (1995a) Próba wykorzystania β-heksozoaminidazy jako markera nadużywania alkoholu w leczeniu uzależnienia. Doniesienie wstȩpne. Postȩpy Psychiatrii i Neurologii 4:181-188.
7. Habrat B, Czartoryska B, Górska D, Poźniak M, Wehr H (1995b) Urine β-hexosaminidase as a marker of sobriety monitoring. Alcohol Alcohol 30:556-556.
8. Helander A, Carlsson S (1996) Carbohydrate-deficient transferrin and gamma-glutamyltransferase levels during disulfiram therapy. Alcohol Clin Exp Res 20:1202-1205.
9. Helander A, Carlson AV, Borg S (1996) Longitudinal comparison of carbohydrate-deficient transferrin and gamma-glutamyltransferase: complementary markers of excessive alcohol consumption. Alcohol Alcohol 31:101-107.
10. Huseby N-E, Nilssen O, Erfurth A, Wetterling T, Kanitz RD (1997a) Carbohydrate-deficient transferrin and alcohol dependency: variation in response to alcohol intake among different groups of patients. Alcohol Clin Exp Res 21:201-205.
11. Huseby N-E, Nilssen O, Kanitz RD (1997b) Evaluation of two biological markers combined as a parameter of alcohol dependency. Alcohol Alcohol 32:731-737.
12. Kärkkäinen P (1990) Serum and urinary β-hexosaminidase as a markers of heavy drinking. Alcohol Alcohol 25:365-369.
13. Kärkkäinen P, Salaspuro M (1991) β-hexosaminidase in detection of alcoholism and heavy drinking. Alcohol Alcohol 26(Suppl):459-464.
14. Kärkkäinen P, Jokelainen K, Roine R, Suokas A, Salaspuro M (1990) The effects of moderate drinking and abstinence on serum and urinary β-hexosaminidase levels. Drug Alcohol Dependence 25:35-38.
15. Lesch OM, Walter H, Antal J, Heggli DE, Kovacz A, Leitner A, Neumeister A, Stumpf I, Sundrehagen E, Kasper S (1996) Carbohydrate-deficient transferring as a marker of alcohol intake: A study with healthy subjects. Alcohol Alcohol 31:265-271.
16. Marhun D (1976) Rapid colorimetric assay of β-hexosaminidase and N-acetyl β-D-glucosaminide. Clin Chim Acta 73:85-91.
17. Martines D, Morris AI, Cilmore IT, Ansari MA, Patel A, Quayle JA, Billington D (1989) Urinary enzyme output during detoxification of chronic alcoholic patients. Alcohol Alcohol 24:113-120.
18. Matteucci E, Giampietro O (1994) To store urinary enzymes: how and how long? Kidney International 46(Suppl 47):S58-S59.
19. Matteucci E, Gregori G, Pellegrini L, Navalesi R, Giampietro O (1991) Effects of storage time and temperature on urinary enzymes. Clin Chem 37:1436-1441.
20. Meregalli M, Giacomini V, Lino S, Marchetti L, DeFeo T, Cappellini MD, Fiorelli G (1995) Carbohydrate-deficient transferrin in alcohol and nonalcohol abusers with liver disease. Alcohol Clin Exp Res 19:1525-1527.
21. Mitchell C, Simpson D, Chick J (1997) Carbohydrate-deficient transferrin in detecting relapse in alcohol dependence. Drug Alcohol Dependence 48:97-103.
22. Musshoff F, Daldrup Th (1998) Determination of biological markers for alcohol abuse. J Chromatogr B 713:245-264.
23. Reynaud M, Hourcade F, Planche F, Albuisson E, Meunier MN, Planche R (1998) Usfulness of carbohydrate deficient transferrin in alcoholic patients with normal γ-glutamyltranspeptidase. Alcohol Clin Exp Res 22:615-618.
24. Rosman AS, Basu P, Galvin K, Lieber CS (1995) Utility of carbohydrate-deficient transferrin as a marker of relapse in alcoholic patients. Alcohol Clin Exp Res 19:611-616.
25. Rubio M, Caballeria J, Deulofeu R, Caballeria L, Gassó M, Parés A, Vilella A, Giménez A, Ballesta A, Rodés J (1997) Carbohydratedeficient transferrin as a marker of alcohol consumption in male patients with liver disease. Alcohol Clin Exp Res 21:923-927.
26. Salaspuro M (1987) Use of enzymes for the diagnosis of alcoholrelated organ damage. Enzyme 37:87-107.
27. Sillanaukee P (1996) Laboratory markers of alcohol abuse. Alcohol Alcohol 31:613-616.
28. Sillanauke P, Aalto M, Seppä K (1998) Carbohydrate-deficient transferrin and conventional alcohol markers as indicators for brief intervention among heavy drinkers in primary health care. Alcohol Clin Exp Res 22:892-896.
29. Stauber RE, Stepan V, Trauner M, Wilders-Trusching M, Leb G, Krejs GJ (1995) Evaluation of carbohydrate-deficient transferrin for detection of alcohol abuse in patients with liver dysfunction. Alcohol Alcohol 30:171-176.
30. Taracha E, Habrat B, Baran-Furga H, Chmielewska K, Woźniak P, Szukalski B (1999a) Zastosowanie oznaczania aktywności β-heksozoaminidazy w moczu i markerów alkoholizmu w surowicy do identyfikacji osób nadużywaja̧cych alkoholu wśród uzalez̈nionych od opiatów uczestnicza̧cych w programie substytucyjnego leczenia metadonem. Alkoholizm i Narkomania No 1(34):99-110.
31. Taracha E, Habrat B, Chmielewska K, Baran H, Szukalski B (1999b) Zastosowanie oznaczania β-heksozoaminidazy w moczu do diagnostyki nadużywania alkoholu przez osoby uzależnione od opiatów biora̧ce udział w programie substytucyjnego leczenia metadonem. Psychiat Pol 33:215-224.
32. Wehr H, Habrat B, Czartoryska B, Górska D, Poźniak M (1994) Zastosowanie oznaczania beta-heksozoaminidazy w moczu do diagnostyki nadużywania alkoholu. Alkoholizm i Narkomania No 2(16):164-168.
33. Wehr H, Habrat B, Czartoryska B, Górska D, Woronowicz B (1996) Urinary β-hexosoaminidase activity as a marker for sobriety monitoring. Psychiat. Pol 30(Suppl):59-66.
34. Wensing G, Neumann U, Ohnhaus EE, Heidemann HT (1990) Effect of antipyrine and phenobarbital on renal β-glutamyltransferase excretion in human urine. Clin Pharmacol Ther 48:575-581.
35. Zweig MH, Campbel G (1993) Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 39:561-577.